NCT04734405: A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC) |
|
|
| Active, not recruiting | 2b/3 | 432 | Europe | Prof-001, Fluconazole 150 mg, Placebo cream, Placebo capsule | ProFem GmbH, Montavit Ges.m.b.H. | Recurrent Vulvovaginal Candidiasis | 11/22 | 12/22 | | |